financetom
Business
financetom
/
Business
/
Arch Capital Q1 Operating Income Declines, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Arch Capital Q1 Operating Income Declines, Revenue Rises
May 25, 2025 9:13 PM

04:26 PM EDT, 04/29/2025 (MT Newswires) -- Arch Capital ( ACGL ) reported Q1 after-tax operating income Tuesday of $1.54 per diluted share, down from $2.45 a year earlier.

Analysts polled by FactSet expected $1.32.

Net premiums written for the quarter ended March 31 were $4.52 billion, up from $4.09 billion a year earlier.

Analysts expected revenue of $4.56 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NFI Subsidiary Alexander Dennis Announcing Consultation on UK Manufacturing Strategy
NFI Subsidiary Alexander Dennis Announcing Consultation on UK Manufacturing Strategy
Jun 11, 2025
09:19 AM EDT, 06/11/2025 (MT Newswires) -- NFI Group ( NFYEF ) on Wednesday said its subsidiary, Alexander Dennis, is entering into a consultation on a new strategy for its United Kingdom manufacturing operations. The company said that this follows the completion of a detailed business review and is intended to adjust the UK business to changing market dynamics. A...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Johnson & Johnson Says Tremfya Reduces Psoriatic Arthritis Signs, Symptoms in Phase 3b Trial
Johnson & Johnson Says Tremfya Reduces Psoriatic Arthritis Signs, Symptoms in Phase 3b Trial
Jun 11, 2025
09:17 AM EDT, 06/11/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Wednesday that results from its phase 3b Apex trial demonstrated that monoclonal antibody Tremfya significantly reduced signs and symptoms of active psoriatic arthritis and inhibited progression of joint structural damage at 24 weeks compared with placebo. The company said 67% and 63% of patients who received...
DoubleVerify Sees Higher Q2 Revenue; Raises 2025 Revenue Guidance
DoubleVerify Sees Higher Q2 Revenue; Raises 2025 Revenue Guidance
Jun 11, 2025
09:28 AM EDT, 06/11/2025 (MT Newswires) -- DoubleVerify ( DV ) said Wednesday that it expects Q2 revenue to be in the range of $180 million to $184 million, up 17% at the midpoint. Analysts polled by FactSet expect $171.1 million. The company said it now expects 2025 revenue to grow 13%. That compares with the company's prior growth expectation...
Copyright 2023-2026 - www.financetom.com All Rights Reserved